Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTC299 in Neurofibromatosis Type 2
NCT00911248Phase 2Terminated
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Jul 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emvododstat in neurofibromatosis type 2 (NF2), sponsored by PTC Therapeutics, Inc.. Started Jul 2009; status: terminated.
02
Drugs
emvododstat
03
Conditions
neurofibromatosis type 2 (NF2)
Beyond the preview
Go deeper on NCT00911248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911248.